Literature DB >> 6230928

Reevaluation of electrocardiographic criteria for left, right and combined cardiac ventricular hypertrophy.

M L Murphy, P N Thenabadu, N de Soyza, J E Doherty, J Meade, B J Baker, J L Whittle.   

Abstract

Cardiac chamber weight was determined at necropsy in 323 men to develop correlative studies of electrocardiographic criteria for ventricular hypertrophy. Thirty recommended criteria for left ventricular (LV) hypertrophy, 10 for right ventricular (RV) hypertrophy, and combinations of both criteria for combined hypertrophy were evaluated. Four methods for electrocardiographic diagnosis of LV hypertrophy were derived: (1) a modification of the Romhilt-Estes point system; (2) the presence of any 1 of 3 criteria: (a) S V1 + R V5 or V6 greater than 35 mm, (b) left atrial abnormality, or (c) intrinsicoid deflection in lead V5 or V6 greater than or equal to 0.05 second; (3) a combination of any 2 criteria or of 1 criterion (above) plus at least 1 of the following 3 additional criteria: (a) left-axis deviation greater than -30 degrees, (b) QRS duration greater than 0.09 second, or (c) T-wave inversion in lead V6 of 1 mm or more; and (4) the use of a single criterion--left atrial abnormality. Sensitivity varied from 57 to 66% and specificity from 85 to 93% among these 4 methods. Myocardial infarction increased sensitivity of the foregoing methods, but the specificity was reduced. Method 2 is preferred for the electrocardiographic diagnosis of LV hypertrophy. Two methods were useful for right ventricular (RV) hypertrophy: (1) the use of any 1 of 4 criteria: (a) R/S ratio in lead V5 or V6 less than or equal to 1; (b) S V5 or V6 greater than or equal to 7 mm; (c) right-axis deviation of more than +90 degrees, or (d) P pulmonale; and (2) use of any 2 combinations of the foregoing criteria. Sensitivity ranged from 18 to 43% and specificity from 83 to 95%. Combined hypertrophy was best diagnosed using left atrial abnormality as the sole criteria of LV hypertrophy, plus any 1 of 3 criteria of RV hypertrophy: (a) R/S ratio in lead V5 or V6 less than or equal to 1, (b) S V5 or V6 greater than or equal to 7 mm, or (c) right axis deviation greater than +90 degrees.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1984        PMID: 6230928     DOI: 10.1016/0002-9149(84)90651-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  Electrocardiogram in a woman with cor pulmonale.

Authors:  D Luke Glancy; Neeraj Jain; Vijayendra R Jaligam; Camelia C Ilie; Prashanthi Atluri
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-07

2.  Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo.

Authors:  P Nuutila; V A Koivisto; J Knuuti; U Ruotsalainen; M Teräs; M Haaparanta; J Bergman; O Solin; L M Voipio-Pulkki; U Wegelius
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

Review 3.  [Standard-ECG].

Authors:  Bernd-Dieter Gonska
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-09

4.  Validity of the surface electrocardiogram criteria for right ventricular hypertrophy: the MESA-RV Study (Multi-Ethnic Study of Atherosclerosis-Right Ventricle).

Authors:  Isaac R Whitman; Vickas V Patel; Elsayed Z Soliman; David A Bluemke; Amy Praestgaard; Aditya Jain; David Herrington; Joao A C Lima; Steven M Kawut
Journal:  J Am Coll Cardiol       Date:  2013-09-28       Impact factor: 24.094

5.  Models for improved diagnosis of left ventricular hypertrophy based on conventional electrocardiographic criteria.

Authors:  Nan Lu; Jin-Xiu Zhu; Pei-Xuan Yang; Xue-Rui Tan
Journal:  BMC Cardiovasc Disord       Date:  2017-08-08       Impact factor: 2.298

6.  ECG Markers of Hemodynamic Improvement in Patients with Pulmonary Hypertension.

Authors:  Marcin Waligóra; Anna Tyrka; Piotr Podolec; Grzegorz Kopeć
Journal:  Biomed Res Int       Date:  2018-04-10       Impact factor: 3.411

7.  Utility of the amplitude of RV1+SV5/6 in assessment of pulmonary hypertension.

Authors:  Sachiyo Igata; Nobuhiro Tahara; Yoichi Sugiyama; Munehisa Bekki; Jun Kumanomido; Atsuko Tahara; Akihiro Honda; Shoko Maeda; Kazutaka Nashiki; Tomohisa Nakamura; Jiahui Sun; Toshi Abe; Yoshihiro Fukumoto
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

8.  The Relationship between Electrocardiographic Changes and Prognostic Factors in Severely Symptomatic Pulmonary Hypertension.

Authors:  Seyed Reza Seyyedi; Babak Sharif-Kashani; Makan Sadr; Mandana Chitsazan; Majid Malekmohammad; Atefeh Abedini; Fateme Monjazebi; Farah Naghashzadeh
Journal:  Tanaffos       Date:  2019-01

Review 9.  Hospital and intensive care unit management of decompensated pulmonary hypertension and right ventricular failure.

Authors:  Angel Coz Yataco; Melina Aguinaga Meza; Ketan P Buch; Margaret A Disselkamp
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

10.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Intensive care management of pulmonary hypertension.

Authors:  M Ali Al-Azem; Manal S Al-Hazmi
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.